First EU citizens using ePrescriptions in other EU country

21 January 2019
europe_big

Today, the first patients in the European Union can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country.

Specifically, Finnish patients are now able to go to a pharmacy in Estonia and retrieve medicine prescribed electronically by their doctor in Finland.

The initiative applies to all ePrescriptions prescribed in Finland and to the Estonian pharmacies that have signed the agreement. The novelty of this initiative is that the ePrescriptions are visible electronically to participating pharmacists in the receiving country via the new eHealth Digital Service Infrastructure, without the patient having to provide a written prescription. This is in line with the European Commission’s policy on Digital Health and Care, which aims to empower patients by giving access to their health data and ensuring continuity of care.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical